======= CARD17 =======
== Gene Information ==
* **Official Symbol**: CARD17
* **Official Name**: caspase recruitment domain family member 17
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=440068|440068]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q5XLA6|Q5XLA6]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CARD17&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CARD17|Open PubMed]]
* **OMIM**: N/A
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Regulator of procaspase-1/CASP1 activation implicated in the regulation of the proteolytic maturation of pro-IL-1beta/IL1B and its release during inflammation. Inhibits the release of IL1B in response to LPS in monocytes. However, unlike CASP1, do not induce NF-kappa-B activation. {ECO:0000269|PubMed:15383541}.
|CARD|
|caspase binding|
|negative regulation of interleukin-1 beta secretion|
|negative regulation of interleukin-1 secretion|
|negative regulation of interleukin-1 beta production|
|negative regulation of interleukin-1 production|
|cysteine-type endopeptidase inhibitor activity|
|regulation of interleukin-1 beta secretion|
|regulation of interleukin-1 secretion|
|negative regulation of cytokine secretion|
|regulation of interleukin-1 beta production|
|regulation of interleukin-1 production|
|negative regulation of protein secretion|
|negative regulation of peptide secretion|
|negative regulation of protein transport|
|cellular response to lipopolysaccharide|
|negative regulation of establishment of protein localization|
|cellular response to molecule of bacterial origin|
|negative regulation of secretion by cell|
|regulation of cytokine secretion|
|cellular response to biotic stimulus|
|negative regulation of secretion|
|negative regulation of endopeptidase activity|
|negative regulation of peptidase activity|
|negative regulation of cytokine production|
|response to lipopolysaccharide|
|response to molecule of bacterial origin|
|negative regulation of proteolysis|
|regulation of endopeptidase activity|
|regulation of peptidase activity|
|negative regulation of hydrolase activity|
|regulation of protein secretion|
|negative regulation of transport|
|regulation of peptide secretion|
|cellular response to lipid|
|protein-containing complex|
|response to bacterium|
|regulation of cytokine production|
|regulation of protein transport|
|regulation of proteolysis|
|regulation of peptide transport|
|regulation of establishment of protein localization|
|regulation of secretion by cell|
|negative regulation of catalytic activity|
|regulation of secretion|
|response to lipid|
|regulation of protein localization|
|negative regulation of cellular protein metabolic process|
|cellular response to oxygen-containing compound|
|identical protein binding|
|negative regulation of protein metabolic process|
|negative regulation of molecular function|
|negative regulation of multicellular organismal process|
|regulation of hydrolase activity|
|response to other organism|
|response to external biotic stimulus|
|response to biotic stimulus|
|regulation of apoptotic process|
|response to oxygen-containing compound|
|regulation of programmed cell death|
|regulation of cell death|
|regulation of transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp47|Lapatinib 5μM R01 exp47]]|-2.1|
|[[:results:exp61|YM155 0.0002μM R01 exp61]]|1.78|
|[[:results:exp471|Cholesterol 0.003 to 0.006 to 0.1μM on day2 then day6 R08 exp471]]|1.98|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 17926
* **Expression level (log2 read counts)**: -6.6
{{:chemogenomics:nalm6 dist.png?nolink |}}